Chapter 95

Reference

  1. Agut A, Laredo FG, Belda E, et al. 2004. Left perinephric abscess associated with nephrolithiasis and bladder calculi in a bitch. Vet Rec 154:562-565.
  2. Anfinsen KP, Berendt M, Liste FJH, et al. 2008. A retrospective epidemiological study of clinical signs and familial predisposition associated with aseptic meningitis in the Norwegian population of Nova Scotia duck tolling retrievers born 1994-2003. Can J Vet Res 72:350-355.
  3. Arnow PM, Flaherty JP. 1997. Fever of unknown origin. Lancet 350:575-580.
  4. Axelrod P. 2000. External cooling in the management of fever. Clin Infect Dis 31(Suppl 5):S224-S229.
  5. Bathen-Noethen A, Carlson R, Menzel D, et al. 2008. Concentrations of acute-phase proteins in dogs with steroid responsive meningitis-arteritis. J Vet Intern Med 22:1149-1156.
  6. Battersby IA, Murphy KF, Tasker S, et al. 2006. Retrospective study of fever in dogs: laboratory testing, diagnoses, and influence of prior treatment. J Small Anim Pract 47:370-376.
  7. Behr S, Cauzinille L. 2006. Aseptic suppurative meningitis in juvenile boxer dogs: retrospective study of 12 cases. J Am Anim Hosp Assoc 42:277-282.
  8. Blatteis CM, Sehic E, Li S. 2000. Pyrogen sensing and signaling: old views and new concepts. Clin Infect Dis 31(Suppl 5):S168-S177.
  9. Botting RM. 2000. Mechanism of action of acetaminophen: is there a cyclooxygenase 3? Clin Infect Dis 31(Suppl 5):S202-S210.
  10. Bouchama A, Hammami MM, Al Shail E, et al. 2000. Differential effects of in vitro and in vivo hyperthermia on the production of interleukin 10. Intensive Care Med 26:1646-1651.
  11. Bouchama A, Knochel JP. 2002. Heat stroke. N Engl J Med 346:1978-1988.
  12. Boulant JA. 2000. Role of the preoptic-anterior hypothalamus in thermoregulation and fever. Clin Infect Dis 31(Suppl 5):S157-S161.
  13. Breitschwerdt EB, Abrams-Ogg ACG, Lappin MR, et al. 2002. Molecular evidence supporting Ehrlichia canis-like infection in cats. J Vet Intern Med 16:642-649.
  14. Bryan CS, Ahuja D. 2007. Fever of unknown origin: is there a role for empiric therapy? Infect Dis Clin N Am 21:1213-1220.
  15. Calvert CA. 1982. Valvular bacterial endocarditis in the dog. J Am Vet Med Assoc 180:1080-1084.
  16. Calvert CA, Greene CE. 1986. Bacteraemia in dogs: diagnosis, treatment and prognosis. Compend Contin Educ Pract Vet 8:179-186.
  17. Calvert CA, Greene CE, Hardie EM. 1985. Cardiovascular infections in dogs: epizootiology, clinical manifestations and prognosis. J Am Vet Med Assoc 187:612-616.
  18. Cerón JJ, Eckersall PD, Martínez-Subiela S. 2005. Acute phase proteins in dogs and cats: current knowledge and future perspectives. Vet Clin Pathol 34:85-99.
  19. Chabanne L, Monier JC, Fournel C, et al. 1999. Canine systemic lupus erythematosus. Part I. Clinical and biologic aspects. Compend Contin Educ Pract Vet 21:135-141.
  20. Chabanne L, Rigal D, Fournel C, et al. 1999. Canine systemic lupus erythematosus. Part II. Diagnosis and treatment. Compend Contin Educ Pract Vet 21:402-421.
  21. Clark RA. 1999. Activation of the neutrophil respiratory burst oxidase. J Infect Dis 179(Suppl 2):S309-S317.
  22. Clements DN, Gear RNA, Tattersall J, et al. 2004. Type I immune-mediated polyarthritis in dogs: 39 cases (1997-2002). J Am Vet Med Assoc 224:1323-1327.
  23. Couto CG. 1998. Hematology and immunology. In Nelson RW, Couto CG (eds): Small animal internal medicine, ed 2. Mosby, St Louis.
  24. Davies GR, Finch RG. 2001. Fever of unknown origin. Clin Med 1:177-179.
  25. Dinarello CA. 1999. Cytokines as endogenous pyrogens. J Infect Dis 179(Suppl 2):S294-S304.
  26. Dinarello CA, Gatti S, Bartfai T. 1999. Fever: links with an ancient receptor. Curr Biol 9:R147-R150.
  27. Dow SW, Jones RL. 1989. Bacteraemia: pathogenesis and diagnosis. Compend Contin Educ Pract Vet 11:423-443.
  28. Dunn JK, Greene CE. 1998. Fever. In Greene CE (ed): Infectious diseases of the dog and cat, ed 2. WB Saunders, Philadelphia.
  29. Dunn KJ. 1996. Personal communication. University of Cambridge, UK.
  30. Dunn KJ, Bujdoso R, Herrtage ME. 1995. Decrease in cell-surface expression of CD11 and CD18 by neutrophils isolated from dogs with pyrexia, p 62. In Proceedings of the 5th Annual Congress of the European Society of Veterinary Internal Medicine, Cambridge, UK.
  31. Dunn KJ, Dunn JK. 1998. Diagnostic investigations in 101 dogs with pyrexia of unknown origin. J Small Anim Pract 39:574-580.
  32. Duval D, Mahaffey E. 1996. Predicted mean corpuscular volume as an indication of bone marrow iron in anemic dogs. Veterinary Clinical Pathol 25:95-98.
  33. Elwood CM, Cobb, MA, Stepien RL. 1993. Clinical and echocardiographic findings in 10 dogs with vegetative bacterial endocarditis. J Small Anim Pract 34:420-427.
  34. Flood J. 2009. The diagnostic approach to fever of unknown origin in cats. Compend Contin Educ Pract Vet 31:26-31.
  35. Flood J. 2009. The diagnostic approach to fever of unknown origin in dogs. Compend Contin Educ Pract Vet 31:14-20.
  36. German AJ, Foster AP, Holden D, et al. 2003. Sterile nodular panniculitis and pansteatitis in three Weimaraners. J Small Anim Pract 44:449-455.
  37. Granick JL, Armstrong PJ, Bender JB. 2009. Anaplasma phagocytophilum infection in dogs: 34 cases (2000-2007). J Am Vet Med Assoc 234:1559-1565.
  38. Greene CE. 1990. Fever, pp 64-71. In Greene CE (ed), Infectious diseases of the dog and cat, ed 1. WB Saunders, Philadelphia.
  39. Hall DM, Buettner GR, Oberley LW, et al. 2001. Mechanisms of circulatory and intestinal barrier dysfunction during whole body hyperthermia. Am J Physiol Heart Circ Physiol 280:H509-H521.
  40. Hardie EM, Rawlings CA, Calvert CA. 1986. Severe sepsis in selected small animal patients. J Am Anim Hosp Assoc 22:33-41.
  41. Hasday JD, Garrison A. 2000. Antipyretic therapy in patients with sepsis. Clin Infect Dis 31(Suppl 5):S234-S241.
  42. Henson KL, Alleman AR, Fox LE, et al. 1998. Diagnosis of disseminated adenocarcinoma by bone marrow aspiration in a dog with leukoerythroblastosis and fever of unknown origin. Vet Clin Pathol 27:80-84.
  43. Hirsch DC, Jang SS, Biberstein EC. 1984. Blood culture of the canine patient. J Am Vet Med Assoc 184:175-178.
  44. Hirschmann JV. 1997. Fever of unknown origin in adults. Clin Infect Dis 24:291-302.
  45. Hoffman SB. 2001. Mechanisms of antibiotic resistance. Compend Contin Educ Pract Vet 23:464-472.
  46. Jiang Q, Cross AS, Singh IS, et al. 2000. Febrile core temperature is essential for optimal host defense in bacterial peritonitis. Infect Immun 68:1265-1270.
  47. Jiang Q, DeTolla L, Kalvakolanu I. 1999. Febrile range temperature modifies early systemic TNF-α expression in mice challenged with bacterial endotoxin. Infect Immun 67:1539-1546.
  48. Jiang Q, DeTolla L, Kalvakolanu I. 1999. Fever upregulates expression of pyrogenic cytokines in endotoxin-challenged mice. Am J Physiol 276:R1653-R1660.
  49. Johannes CM, Cohn LA. 2000. A clinical approach to patients with fever of unknown origin. Vet Med 95:633-642.
  50. Komori S, Nakagaki K, Koyama H, et al. 2002. Idiopathic mesenteric and omental steatitis in a dog. J Am Vet Med Assoc 221:1591-1593.
  51. Lappin MR. 2000. Fever in cats. Proc ACVIM Forum 18:18-22.
  52. Lenhardt R, Negishi C, Sessler DI, et al. 1999. The effects of physical treatment of induced fever in humans. Am J Med 106:550-555.
  53. Leon LR, Kozak W, Rudolph K, et al. 1999. An antipyretic role for interleukin-10 in LPS fever in mice. Am J Physiol 276:R81-R89.
  54. Li S, Sehic E, Wang Y, et al. 1999. Relation between complement and the febrile response of guinea pigs to systemic endotoxin. Am J Physiol 277:R1635-R1645.
  55. Lilliehöök I, Gunnarsson L, Zakrisson G, et al. 2000. Diseases associated with pronounced eosinophilia: a study of 105 dogs in Sweden. J Small Anim Pract 41:248-253.
  56. Lowrie M, Penderis J, McLaughlin M, et al. 2009. Steroid responsive meningitis-arteritis: a prospective study of potential disease markers, prednisolone treatment, and long-term outcome in 20 dogs (2006-2008). J Vet Intern Med 23:862-870.
  57. Lunn KF. 2001. Fever of unknown origin: a systematic approach to diagnosis. Compend Contin Educ Pract Vet 23:976-992.
  58. Mackowiak PA. 2000. Antipyretic therapy's future. Clin Infect Dis 31(Suppl 5):S242-S243.
  59. Mackowiak PA. 2000. Brief history of antipyretic therapy. Clin Infect Dis 31(Suppl 5):S154-S156.
  60. Mackowiak PA. 2000. Diagnostic implications and clinical consequences of antipyretic therapy. Clin Infect Dis 31(Suppl 5):S230-S233.
  61. Mackowiak PA. 2000. Introduction: antipyretic therapy. Clin Infect Dis 31(Suppl 5):S153.
  62. Mackowiak PA. 2000. Physiological rationale for suppression of fever. Clin Infect Dis 31(Suppl 5):S185-S189.
  63. Mackowiak PA. 2000. Temperature regulation and the pathogenesis of fever, pp 604-622. In Mandell GL, Douglas RG, Bennett JE (eds): Principles and practice of infectious diseases, ed 5. Churchill Livingstone, Philadelphia.
  64. Mackowiak PA, Bartlett JG, Borden EC, et al. 1997. Concepts of fever: recent advances and lingering dogma. Clin Infect Dis 25:119-138.
  65. Marik PE. 2000. Fever in the ICU. Chest 117:855-869.
  66. Mazepa AW, Kidd LB, Young KM, et al 2010. Clinical presentation of 26 Anaplasma phagocytophilum-seropositive dogs residing in an endemic area. J Am Anim Hosp Assoc 46:405-412.
  67. McCarthy PL. 2004. Fever without apparent source on clinical examination. Curr Opin Pediatr 16:94-106.
  68. Meller J, Sahlmann C-O, Scheel AK. 2007. 18F-FDG PET and PET/CT in fever of unknown origin. J Nucl Med 48:35-45.
  69. Mylotte JM, Tayara A. 2000. Blood cultures: clinical aspects and controversies. Eur J Clin Microbiol Infect Dis 19:157-163.
  70. Netea MG, Kullberg BJ, Van der Meer JWM. 1999. Do only circulating pyrogenic cytokines act as mediators in the febrile response? A hypothesis. Eur J Clin Invest 29:351-356.
  71. Netea MG, Kullberg BJ, Van der Meer JWM. 2000. Circulating cytokines as mediators of fever. Clin Infect 31(Suppl 5):S178-S184.
  72. O’Banion MK. 1999. Cyclooxygenase 2: molecular biology, pharmacology, and neurobiology. Crit Rev Neurobiol 13:45-82.
  73. O’Grady NP, Barie PS, Bartlett JG, et al. 2008. Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America. Crit Care Med 36:1330-1349.
  74. Øvrebø Bohnhorst J, Hanssen I, Moen T. 2002. Immune-mediated fever in the dog. Occurrence of antinuclear antibodies, rheumatoid factor, tumor necrosis factor and interleukin-6 in serum. Acta Vet Scand 43:165-171.
  75. Pedersen NC, Morgan JP, Vasseur PB. 2000. Joint diseases of dogs and cats. In Ettinger SJ, Feldman EC (eds): Textbook of veterinary internal medicine, ed 5. WB Saunders, Philadelphia.
  76. Peters RPH, van Agtmael MA, Danner SA, et al. 2004. New developments in the diagnosis of bloodstream infections. Lancet Infect Dis 4:751-760.
  77. Pinals RS. 1994. Polyarthritis and fever. N Engl J Med 330:769-774.
  78. Plaisance KI. 2000. Toxicities of drugs used in the management of fever. Clin Infect Dis 31(Suppl 5):S219-S223.
  79. Plaisance KI, Mackowiak PA. 2000. Antipyretic therapy: physiologic rationale, diagnostic implications, and clinical consequences. Arch Intern Med 160:449-456.
  80. Rennen HJJM, Boerman OC, Oyen WJG, et al. 2001. Imaging infection/inflammation in the new millennium. Eur J Nucl Med 28:241-252.
  81. Romanovsky AA, Ivanov AI, Berthoud HR, et al. 2000. Are vagal efferents involved in the fever response to intraperitoneal lipopolysaccharide? J Therm Biol 25:65-70.
  82. Romanovsky AA, Ivanov AI, Karman EK. 1999. Blood-borne, albumin-bound prostaglandin E2 may be involved in fever. Am J Physiol 276:R1840-R1844.
  83. Romanovsky AA, Ivanov AI, Székely M. 2000. Neural route of pyrogen signaling to the brain. Clin Infect Dis 31(Suppl 5):S162-S167.
  84. Rondeau MP, Walton RM, Bissett S, et al. 2005. Suppurative, nonseptic polyarthropathy in dogs. J Vet Intern Med 19:654-662.
  85. Simmons DL, Wagner D, Westover K. 2000. Nonsteroidal anti-inflammatory drugs, acetaminophen, cyclooxygenase 2, and fever. Clin Infect Dis 31(Suppl 5):S211-S218.
  86. Sorenmo KU, Hafrwood LP, King LG, et al. 2010. Case-control study to evaluate risk factors for the development of sepsis (neutropenia and fever) in dogs receiving chemotherapy. J Am Vet Med Assoc 236:650-656.
  87. Spector D, Legendre AM, Wheat J, et al. 2008. Antigen and antibody testing for the diagnosis of blastomycosis in dogs. J Vet Intern Med 22:839-843.
  88. Steiner AA, Blatteis CM. 2000. COX-2 is an essential modulator of LPS fever in guinea pigs. FASEB J 14:A86.
  89. Stull JW, Evason M, Carr AP, et al. 2008. Canine immune-mediated polyarthritis: clinical and laboratory findings in 83 cases in western Canada (1991-2001). Can Vet J 49:1195-1203.
  90. Swartz J, Chan CC, Mukhopadhyay S, et al. 1999. Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans. Clin Pharmacol Ther 65:653-660.
  91. Sykes JE, Kittleson MD, Chomel BB, et al. 2006. Clinicopathological findings and outcome in dogs with infective endocarditis: 71 cases (1992-2005). J Am Vet Med Assoc 228:1735-1747.
  92. Sykes JE, Kittleson MD, Pesavento PA, et al. 2006. Evaluation of the relationship between causative organisms and clinical characteristics of infective endocarditis in dogs: 71 cases (1992–2005). J Am Vet Med Assoc 228:1723-1734.
  93. Tatro JB. 2000. Endogenous antipyretics. Clin Infect Dis 31(Suppl 5):S190-S201.
  94. Trepanier LA. 2004. Idiosyncratic toxicity associated with potentiated sulfonamides in the dog. J Vet Pharmacol Ther 27:129-138.
  95. Trepanier LA, Danhof R, Toll J, et al. 2003. Clinical findings in 40 dogs with hypersensitivity associated with administration of potentiated sulfonamides. J Vet Intern Med 17:647-652.
  96. Wall M, Calvert CA, Greene, CE. 2002. Infective endocarditis in dogs. Compend Contin Educ Pract Vet 24:614-625.
  97. Wang ZZ, Wang CL, Wu TC, et al. 2001. Autoantibody response to heat shock protein 70 in patients with heatstroke. Am J Med 111:654-657.
  98. Ward PA, Lentsch AB. 1999. The acute inflammatory response and its regulation. Arch Surg 134:666-669.
  99. Webb AA, Taylor SM, Muir GD. 2002. Steroid-responsive meningitis-arteritis in dogs with non-infectious, nonerosive, idiopathic, immune-mediated polyarthritis. J Vet Intern Med 16:269-273.
  100. Weiss DJ. 2007. Hemophagocytic syndrome in dogs: 24 cases (1996-2005). J Am Vet Med Assoc 230:697-701.
  101. Wess G, Unterer S, Haller M, et al. 2003. Recurrent fever as the only or predominant clinical sign in four dogs and one cat with congenital portosystemic vascular anomalies. Schweiz Arch Tierheilkd 145: 363-368.
  102. Wolf AM. 1993. Fever of undetermined origin in the cat. Feline Pract 21:6-8.
  103. Yanay O, Barry SC, Katen LJ, et al. 2003. Treatment of canine cyclic neutropenia by lentivirus-mediated G-CSF delivery. Blood 102:2046-2052.